Newstral
Article
Sydney Morning Herald on 2020-02-04 13:45
Biotech giant CSL looks to join the defence against coronavirus
Related news
- Startups join CSL, Moderna in local mRNA vaccine manufacturing pushSydney Morning Herald
- Here’s what our $132b biotech giant plans to do nextSydney Morning Herald
- Australian biotech firm CSL joins race for coronavirus treatmentThe Jerusalem Post (JPost.com)
- CSL, Cochlear seek incentives to keep biotech manufacturing localSydney Morning Herald
- 'Watch out CSL, here we come': biotech gears to go globaltheage.com.au
- Australia's planned defence inventory already looks obsoleteSydney Morning Herald
- ‘Very appealing’: US vaccine giant looks to amp up Australian trialsSydney Morning Herald
- PBiotech giant Amgen looks to out-license technologypacbiztimes.com
- CSL shares hit $100news.com.au
- Diggers need to join Iraq battlefield, defence experts saySydney Morning Herald
- GPs join election fight in defence of MedicareSydney Morning Herald
- Australia looks at defence overhaul amid Chinese growthexpressandstar.com
- CSL acquires intravenous flu drugnews.com.au
- LVaccines & Vaccination Market 2021 High Growth Forecast due to Rising Demand and Future Trends | Key Companies: Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med, CSL, Emergen…liverpoolstudentmedia.com
- LGlobal Vaccines & Vaccination Market 2021 Financial Insights, Business Growth Strategies, Trends | Market Players: Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med, CSL, Emer…liverpoolstudentmedia.com
- G“Global Antivenom Market 2022-28 Top Players: CSL ,Merck ,BTG ,Pfizer ,Haffkine Bio-Pharmaceutical ,Rare Disease Therapeutics ,Flynn Pharma ,Vins Bioproducts ,Bharat Serums and Vaccines ,Serum Biotech ,MicroPharm ,”galleonnews.com
- 'Very optimistic': Tech giant Adobe looks to Australia for growthSydney Morning Herald
- Markets Live: ASX rises on CSL, ComputershareSydney Morning Herald
- CSL leads ASX's healthy gains in JulySydney Morning Herald